Labshake search
Citations for Stemcell Technologies :
51 - 100 of 383 citations for 7 CYANO 4 HYDROXY 3 QUINOLINECARBOXYLIC ACID since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... ascorbic acid (200 μM, #72132; StemCell Technologies), GDNF (20 ng/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.2 M ascorbic acid (STEMCELL Technologies).
-
Prevention of tau accumulation through inhibition of hnRNP R-dependent axonal Mapt mRNA localizationbioRxiv - Neuroscience 2023Quote: ... 1 µM retinoic acid (72264, Stemcell Technologies) was added to the medium ...
-
bioRxiv - Neuroscience 2023Quote: ... non-essential amino acids (NEAA, Stemcell technologies). After 24h (day0) ...
-
bioRxiv - Biochemistry 2022Quote: ... 0.2 mM ascorbic acid (Stem cell technologies), 20ng/ml BDNF (Petrotech ...
-
bioRxiv - Molecular Biology 2019Quote: ... iPSCs were passaged every 5-7 days using ReLeSR (Stem Cell Technologies).
-
bioRxiv - Bioengineering 2021Quote: ... Cells were passaged every 6–7 days using Dispase (Stemcell Technologies, Canada). Differentiated colonies were removed manually by scraping ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 200 nM ascorbic acid (Stemcell Technologies,72132) till desired time ...
-
bioRxiv - Neuroscience 2020Quote: ... Cells were maintained with media changes every 3-4 days with full neural culture media consisting of BrainPhys™ Basal Media (STEMCELL Technologies, Vancouver, BC, Canada) or Advanced DMEM/F12 (ThermoFisher ...
-
bioRxiv - Molecular Biology 2020Quote: ... using a working solution including 7 mL of Optiprep™ (#07820, Stemcell Technologies) with 1.4 mL of working buffer (0.25 M sucrose (200-334-9 ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were passaged by 7-min incubation with Dispase (STEMCELL Technologies, Vancouver, Canada). All hESCs have tested negative for mycoplasma.
-
bioRxiv - Developmental Biology 2024Quote: ... cells were split every 5-7 days with accutase (Stem Cell Technologies, #07920) (Bajpai et al. ...
-
Safety and efficacy of C9ORF72-repeat RNA nuclear export inhibition in amyotrophic lateral sclerosisbioRxiv - Systems Biology 2021Quote: ... All-Trans Retinoic Acid 0.1 µM (RA; StemCell Technologies) and Purmorphamine 0.5 µM (PMN ...
-
bioRxiv - Neuroscience 2022Quote: ... 3.52 μg/mL Ascorbic acid (Stem cell technologies # 72132), 0.5mM L-glutamine and 1% NEAA and then plated on to T25 flasks ...
-
bioRxiv - Molecular Biology 2022Quote: ... and 10 µM ascorbic acid (AA) (Stemcell Technologies 72132). Day 2 ...
-
bioRxiv - Neuroscience 2022Quote: ... Ascorbic acid (200 nM, Cat. No. 72132 STEMCELL Technologies), and laminin (1 μg/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... and Am580 retinoic acid agonist 2.5 μM (STEMCELL Technologies) at 2 × 106 cells/mL density ...
-
bioRxiv - Neuroscience 2024Quote: ... and 200 nM Ascorbic Acid (#72132; Stem Cell Technology). From day 43 to 120 ...
-
bioRxiv - Bioengineering 2022Quote: ... and interleukin-3 (IL-3; 1 ng/mL, first day only; Stemcell Technologies; Canada). Cell density was maintained between 0.7-2×106 cells/mL by daily feeding with fresh expansion medium.
-
bioRxiv - Genomics 2020Quote: ... 3 µM CHIR99021 (Stemcell Technologies), 1 µM PD0325901 (Stemcell Technologies) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 3 μM CHIR99021 (STEMCELL Technologies), 1 μM PD0325901 (STEMCELL Technologies) ...
-
bioRxiv - Immunology 2024Quote: ... + 3 µM CHIR9902 (Stemcell Technologies) + 10 µM SB-431542 (Stemcell Technologies ...
-
bioRxiv - Biochemistry 2022Quote: ... Cells were passaged every 5-7 days using ReLeSR (STEMCELL Technologies, Vancouver, BC, Canada) and maintained within passages 20 to 50.
-
bioRxiv - Microbiology 2023Quote: ... ascorbic acid (50 μg/ml, STEMCELL Technologies, Cat# ST-72132), 1 × GlutaMAX (Thermo Fisher Scientific ...
-
bioRxiv - Immunology 2021Quote: ... and 3 mM CHIR (StemCell Technologies)) ...
-
bioRxiv - Immunology 2019Quote: ... clone IV.3 (STEMCELL Technologies; 60012FI); Brilliant Violet 711 conjugated anti-human FcγRIII ...
-
bioRxiv - Cell Biology 2020Quote: ... 3 µM CHIR99021 (CHIR, STEMCELL Technologies) and 100 ng/mL Activin A (Biotechne) ...
-
bioRxiv - Cell Biology 2021Quote: ... CHIR99021 3 µm (72052 StemCell Technologies), DMSO (final concentration 0.05% ...
-
bioRxiv - Cancer Biology 2023Quote: ... + 10ng/ml IL-3 (STEMCELL Technologies). The WSU-AML cell line was also seeded at 1x106 cells/ml ...
-
bioRxiv - Bioengineering 2021Quote: ... then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 μM all-trans retinoic acid (RA, STEMCELL Technologies, 72262), and the removal of Glial Cell Derived Neurotrophic Factor (GDNF).
-
bioRxiv - Bioengineering 2021Quote: ... and 0.1 μM all-trans retinoic acid (Stem Cell Technologies; 72262) for 5 days ...
-
bioRxiv - Molecular Biology 2019Quote: ... and 10 µM all-trans retinoic acid (ATRA, Stemcell Technologies, 72264) (Differentiation Medium 1) ...
-
bioRxiv - Genomics 2020Quote: ... All-Trans Retinoic Acid 0.1 μM (RA, STEMCELL Technologies, Cat.: #72262), and Purmorphamine 0.5 μM (PMN ...
-
bioRxiv - Immunology 2021Quote: ... 50 μg/ml L-ascorbic acid (L-AA, Stem Cell Technologies) and 6 μg/ml holo-transferrin (Sigma) ...
-
bioRxiv - Cell Biology 2020Quote: ... and 3 units/mL EPO (STEMCELL Technologies) in the presence of 1 µM GSK-J4 (Sigma ...
-
bioRxiv - Physiology 2020Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies), 500 μg/mL BSA (Sigma Aldrich) ...
-
bioRxiv - Cancer Biology 2022Quote: ... Interleukin-3 (IL3, StemCell Technologies, Cat#78194) and Interleukin-6 (IL6 ...
-
bioRxiv - Immunology 2021Quote: ... anti-CD32 (STEMCELL Technologies; clone IV.3), anti-CD32B/C (clone S18005H) ...
-
bioRxiv - Microbiology 2020Quote: ... CHIR 99021 3 µM (Stemcell Technologies, 72054), Pumorphamine 1 µM (Miltenyi Biotec ...
-
bioRxiv - Developmental Biology 2021Quote: ... 3 µM CHIR99021 (STEMCELL Technologies, cat#72054), 100 nM All-trans Retinoic acid (ATRA ...
-
bioRxiv - Systems Biology 2021Quote: ... 3 µM CHIR99021 (72054, Stem Cell Technologies) and 1 µM PD0325901 (72184 ...
-
bioRxiv - Cell Biology 2021Quote: ... 100μg/mL hrIL-3 (StemCell Technologies 78040), 10μg/mL hrG-CSF (NEUPOGEN ...
-
bioRxiv - Bioengineering 2022Quote: ... and 3 μM CHIR-99021 (Stemcell Technologies). After 4-day culture in SCM I ...
-
bioRxiv - Neuroscience 2022Quote: ... and 3 µM CHIR99021 (STEMCELL Technologies, 72054), was freshly added ...
-
bioRxiv - Immunology 2022Quote: ... -32 (Stemcell Technologies 60012 clone IV.3), or -64 (Biolegend 305002 Clone 10.1).
-
bioRxiv - Genomics 2023Quote: ... 10 µg/mL NT-3 (StemCell Technologies), and 1 mg/mL Mouse Laminin (Gibco) ...
-
bioRxiv - Cell Biology 2023Quote: ... CHIR99021 (3 μM, STEMCELL Technologies, Cat#72052), purmorphamine (0.5 mM ...
-
bioRxiv - Bioengineering 2021Quote: ... and then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 % neomycin and addition of 10 μM retinoic acid (RA) (Stemcell Technologies). At day 6 the cells were washed twice with warm PBS (Sigma-Aldrich ...